| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $2.86 ▲ +2.03% | Yesterday | $2.78 ▼ -0.85% | Tomorrow's Palisade Bio Inc. Common Stock (PALI) setup is anchored to $2.80 and targets $2.86 (+2.03%). The near-term read is upside; watch $2.88 / $2.72 because daily realized volatility is about 8.00%. |
Tomorrow's Palisade Bio Inc. Common Stock (PALI) setup is anchored to $2.80 and targets $2.86 (+2.03%). The near-term read is upside; watch $2.88 / $2.72 because daily realized volatility is about 8.00%. | ||||
| Week | $2.98 ▲ +6.31% | Last Week | $2.73 ▼ -2.65% | The 7-day Palisade Bio Inc. Common Stock model moves from $2.73 to $2.98 (+6.31%). It gives upside momentum context for this stock, so breaks around $2.88 / $2.72 matter more than a single tick. |
The 7-day Palisade Bio Inc. Common Stock model moves from $2.73 to $2.98 (+6.31%). It gives upside momentum context for this stock, so breaks around $2.88 / $2.72 matter more than a single tick. | ||||
| Month | $3.18 ▲ +13.45% | Last Month | $2.64 ▼ -5.65% | The 1-month Palisade Bio Inc. Common Stock target is $3.18 (+13.45%), compared with the live reference near $2.80. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Palisade Bio Inc. Common Stock target is $3.18 (+13.45%), compared with the live reference near $2.80. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $3.48 ▲ +24.14% | Last Year | $2.52 ▼ -10.14% | The 1-year Palisade Bio Inc. Common Stock scenario points to $3.48 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Palisade Bio Inc. Common Stock scenario points to $3.48 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $4.18 ▲ +49.20% | 5 Years Ago | $2.22 ▼ -20.66% | The 5-year Palisade Bio Inc. Common Stock view is $4.18 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Palisade Bio Inc. Common Stock view is $4.18 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $2.80 | Mid |
| Daily Change | +12.00% | Above |
| Volatility Cap | 20.0% | Mid |
| Confidence | 83% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $2.80 | Daily Change | +12.00% |
| Market Cap | $468.79M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.